Your browser doesn't support javascript.
loading
Adaptive RSK-EphA2-GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer.
Moyano-Galceran, Lidia; Pietilä, Elina A; Turunen, S Pauliina; Corvigno, Sara; Hjerpe, Elisabet; Bulanova, Daria; Joneborg, Ulrika; Alkasalias, Twana; Miki, Yuichiro; Yashiro, Masakazu; Chernenko, Anastasiya; Jukonen, Joonas; Singh, Madhurendra; Dahlstrand, Hanna; Carlson, Joseph W; Lehti, Kaisa.
Afiliación
  • Moyano-Galceran L; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Pietilä EA; Research Programs Unit, Individualized Drug Therapy, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Turunen SP; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Corvigno S; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Hjerpe E; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Bulanova D; Department of Obstetrics and Gynecology, Visby Hospital, Visby, Sweden.
  • Joneborg U; Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland.
  • Alkasalias T; Division of Pelvic Cancer, Department of Women's and Children's Health, Karolinska Institutet and University Hospital, Stockholm, Sweden.
  • Miki Y; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Yashiro M; Research Centre, Salahaddin University-Erbil, Erbil, Iraq.
  • Chernenko A; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Jukonen J; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Singh M; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Dahlstrand H; Research Programs Unit, Individualized Drug Therapy, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Carlson JW; Research Programs Unit, Individualized Drug Therapy, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Lehti K; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
EMBO Mol Med ; 12(4): e11177, 2020 04 07.
Article en En | MEDLINE | ID: mdl-32115889
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Transducción de Señal / Resistencia a Antineoplásicos / Proteínas Quinasas S6 Ribosómicas 90-kDa / Receptor EphA2 / Receptores Acoplados a Proteínas G Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: EMBO Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2020 Tipo del documento: Article País de afiliación: Suecia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Transducción de Señal / Resistencia a Antineoplásicos / Proteínas Quinasas S6 Ribosómicas 90-kDa / Receptor EphA2 / Receptores Acoplados a Proteínas G Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: EMBO Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2020 Tipo del documento: Article País de afiliación: Suecia